German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year.
The ambitious turnaround time is thanks to the MRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Malaria kills more than 400,000 people annually, most of them children in sub-Saharan Africa.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Police on manhunt for group over election violence threats
3 mins -
2024/2025 Ghana League: Nsoatreman eye victory against Aduana FC in Bono derby
54 mins -
10 newborns killed in hospital fire in northern India
1 hour -
GPL 2024/25: Vision FC hope to end winless run against Dreams
2 hours -
GPL 2024/25: Relegation-threatened Legon Cities host Basake Holy Stars
2 hours -
Open Letter to Justice (Rtd.) William Atuguba
3 hours -
Pastor Love granted GHȼ2-million bail pending appeal
3 hours -
Karoline Leavitt to become youngest White House press secretary
3 hours -
Trump cabinet picks battle misconduct claims and controversy
4 hours -
Climate Financing Director unveils new initiatives at COP29 Finance Day
4 hours -
Prediabetes – What it is and why you should know about it
4 hours -
Jake Paul beats Mike Tyson via unanimous decision
4 hours -
M.A.T.R.I.A.R.C.H: Nurturing Our Tracks
8 hours -
Unwanted history: Ghana’s AFCON failure a dark chapter for Otto Addo and the Black Stars
10 hours -
Don’t vote for politicians who will collapse indigenous businesses – Dr Nduom tells Ghanaians
10 hours